ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 29

$481K Total Retail Price of All Prescriptions

Rank: 19 out of 29

645 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 645 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 645 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,741 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 438 438 1 1
SIMVASTATIN 379 379 2 4
DONEPEZIL HCL 295 294 3 9
NAMENDA 281 276 4 12
LISINOPRIL 264 263 5 2
OMEPRAZOLE 242 241 6 8
CITALOPRAM HBR 229 219 7 11
POTASSIUM CHLORIDE 211 211 8 6
AMLODIPINE BESYLATE 204 204 9 5
FUROSEMIDE 203 203 10 3
METFORMIN HCL 177 177 11 19
MELOXICAM 176 174 12 36
MIRTAZAPINE 176 176 12 13
WARFARIN SODIUM 175 175 14 14
HYDROCHLOROTHIAZIDE 161 161 15 20
ATENOLOL 157 157 16 23
ZOLPIDEM TARTRATE 132 121 17 30
HYDROCODONE-ACETAMINOPHEN 125 125 S3 18 7
ATORVASTATIN CALCIUM 124 124 19 25
METOPROLOL SUCCINATE 117 117 20 16
ESCITALOPRAM OXALATE 102 102 21 37
TRAZODONE HCL 101 90 22 22
FLUTICASONE PROPIONATE 100 100 23 43
EXELON 99 99 24 38
TRAMADOL HCL 98 98 25 24
GABAPENTIN 91 90 26 10
TAMSULOSIN HCL 89 89 27 31
TRIAMTERENE-HCTZ 89 89 27 48
METOPROLOL TARTRATE 87 87 29 15
NEXIUM 86 86 30 47
DIOVAN 81 81 31 35
CARVEDILOL 76 76 32 27
ALENDRONATE SODIUM 72 72 33 26
DIGOXIN 66 66 34 34
PRAVASTATIN SODIUM 66 65 34 18
EVISTA 62 62 36 55
ISOSORBIDE MONONITRATE ER 61 61 37 44
LOSARTAN POTASSIUM 59 59 38 28
TERAZOSIN HCL 56 56 39 194
DIVALPROEX SODIUM 55 55 40 45
ALLOPURINOL 55 55 40 40
DILTIAZEM 24HR CD 54 54 42 109
PROPRANOLOL HCL 53 53 43 70
SERTRALINE HCL 52 52 44 17
FAMOTIDINE 52 52 44 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 46 64
KLOR-CON M20 50 50 47 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.